Literature DB >> 6275162

Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy.

J K Aronson, A R Ford, D G Grahame-Smith.   

Abstract

We have measured the effects of digoxin on the cation transport mechanisms of patients' erythrocytes during treatment with digoxin for atrial fibrillation and cardiac failure in sinus rhythm. The results show that during short-term treatment with digoxin there is occupation of erythrocytic cardiac glycoside receptors by digoxin with resultant inhibition of active cation transport. These effects correlate well with the patients' clinical responses to treatment. During long-term treatment, however, these effects are not seen, suggesting that there is pharmacological tolerance to the effects of digoxin. The clinical implications of these results are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275162     DOI: 10.1007/bf01720552

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  9 in total

1.  The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects.

Authors:  A Schwartz; G E Lindenmayer; J C Allen
Journal:  Pharmacol Rev       Date:  1975-03       Impact factor: 25.468

2.  The serum digitalis concentration--does it diagnose digitalis toxicity?

Authors:  J A Ingelfinger; P Goldman
Journal:  N Engl J Med       Date:  1976-04-15       Impact factor: 91.245

3.  The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.

Authors:  A R Ford; J K Aronson; D G Grahame-Smith; J A Rose
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

4.  Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.

Authors:  A R Ford; J K Aronson; D G Grahame-Smith; J G Carver
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

5.  The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.

Authors:  A R Ford; J K Aronson; D G Grahame-Smith; J G Carver
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

6.  Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.

Authors:  J K Aronson; D G Grahame-Smith; K F Hallis; A Hibble; F Wigley
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

7.  Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes.

Authors:  E Erdmann; W Hasse
Journal:  J Physiol       Date:  1975-10       Impact factor: 5.182

8.  The use of colour vision measurement in the diagnosis of digoxin toxicity.

Authors:  J K Aronson; A R Ford
Journal:  Q J Med       Date:  1980

9.  Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.

Authors:  J K Aronson; D G Grahame-Smith; F M Wigley
Journal:  Q J Med       Date:  1978-04
  9 in total
  5 in total

1.  David Grahame Grahame-Smith: clinical pharmacologist. 1933-2011.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

2.  Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.

Authors:  S E Pugh; N J White; J K Aronson; D G Grahame-Smith; J G Bloomfield
Journal:  Br Heart J       Date:  1989-06

3.  Influence of digitalis and diuretics on ouabain binding sites on human erythrocytes.

Authors:  E Erdmann; K Werdan; W Krawietz
Journal:  Klin Wochenschr       Date:  1984-01-16

4.  Human skeletal muscle digitalis glycoside receptors (Na,K-ATPase)--importance during digitalization.

Authors:  T A Schmidt; P Holm-Nielsen; K Kjeldsen
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

Review 5.  Biochemical regulators in cardiac hypertrophy.

Authors:  F Kölbel; V Schreiber
Journal:  Basic Res Cardiol       Date:  1983 Jul-Aug       Impact factor: 17.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.